Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients.
about
Oxidative stress and β-thalassemic erythroid cells behind the molecular defectEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Novel approach to reactive oxygen species in nontransfusion-dependent thalassemiaPotential oxidative stress in children with chronic constipationCytoprotective effects of the antioxidant phytochemical indicaxanthin in beta-thalassemia red blood cells.Protection against oxidative stress in beta thalassemia/hemoglobin E erythrocytes by inhibitors of glutathione efflux transporters.Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatmentPromotion of plasma membrane repair by vitamin E.Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable StateEffects of Vitamin E and Zinc Supplementation on Antioxidants in Beta thalassemia major PatientsModern treatment of thalassaemia intermedia.Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT)Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: An Egyptian center experienceOptimal management of β thalassaemia intermedia.Lipoic acid and acetyl-carnitine reverse iron-induced oxidative stress in human fibroblasts.Erythrocytes anion transport and oxidative change in beta-thalassaemias.The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria.Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double-blind, placebo-controlled trial.
P2860
Q26995805-8BDDFE67-701D-4B17-89D8-1780B1F1EE53Q33761211-04917493-B0E7-4812-9BE3-1F2A733F45E0Q33993973-911A0CFE-C547-4232-8A75-CC5F80C471E6Q34382261-A1AD7DCE-F10C-43C6-BFBA-141EE0EA67FFQ34567089-B3BA4B40-214D-4083-8C2C-A9E2232BCB2FQ34576893-618691D0-95FB-429F-96EA-2CCD656DC30FQ35193628-0EC4FC59-104C-4A60-93C9-9BD38EC2A019Q35639232-81467EF9-CC70-4E90-962A-EEFAC3240432Q35675094-7F0519FB-B1D8-4CA6-A9FB-C8491B8A1795Q36244677-1C2643DF-C7E2-46A7-A4B5-E19FE532B2B4Q36848269-6E17FA11-6148-4CCB-902D-55E89010956BQ37151933-E1EFF298-9870-4061-9094-13F222A6115EQ37725498-E5420DF0-1831-4F8C-BE5B-0748A4079E88Q37830724-4C333FDF-7F38-47FF-BD99-61F62AB9F1D7Q40011474-6692BB59-4833-474D-8280-F04F5DFBAE25Q43070068-43155836-08A6-4C7B-9449-B1894134A46DQ44594613-D06BF37C-2BEF-486E-960C-951FA487E3BFQ48326289-EBC8A0C8-E653-41EA-B403-01343945AFA1
P2860
Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Oral supplements of vitamin E ...... alassemia intermedia patients.
@en
Oral supplements of vitamin E ...... alassemia intermedia patients.
@nl
type
label
Oral supplements of vitamin E ...... alassemia intermedia patients.
@en
Oral supplements of vitamin E ...... alassemia intermedia patients.
@nl
prefLabel
Oral supplements of vitamin E ...... alassemia intermedia patients.
@en
Oral supplements of vitamin E ...... alassemia intermedia patients.
@nl
P2093
P2860
P1476
Oral supplements of vitamin E ...... alassemia intermedia patients.
@en
P2093
Bongiorno A
Tesoriere L
P2860
P304
P356
10.1080/10715760100300461
P577
2001-05-01T00:00:00Z